Jove
Visualize
Contact Us

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer.

Journal of medicinal chemistry·2026
Same author

Picolinamide-functionalized macrocyclic chelators for <sup>203/212</sup>Pb theranostic radiotracers.

Inorganic chemistry frontiers·2026
Same author

Cu(ATSM) Restores Blood-Brain Barrier Abundance of P-Glycoprotein and Improves Cognitive Function in the APP/PS1 Mouse Model of Alzheimer's Disease.

ACS chemical neuroscience·2026
Same author

An Evaluation of Cage Amine Sarcophagine Ligands for the Synthesis of Cobalt Radiopharmaceuticals.

Inorganic chemistry·2026
Same author

Phosphorescent Iridium Hydrazinonicotinic Acid (HYNIC) Complexes That Bind to Prostate Specific Membrane Antigen: Potential Photodynamic Therapy of Prostate Cancer.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Collagen-targeted tracers for molecular imaging of atrial fibrosis and sensitive detection of atrial fibrillation.

NPJ cardiovascular health·2026
Same journal

Cosmetic Products Containing Rutin: A Systematic Review of Patents from 2014 to 2024.

Current topics in medicinal chemistry·2026
Same journal

Overview of Immunotherapy in Lung Cancer: Present Landscape.

Current topics in medicinal chemistry·2026
Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026
Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026
Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Peptide targeted copper-64 radiopharmaceuticals.

Michelle T Ma1, Paul S Donnelly

  • 1School of Chemistry, University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.

Current Topics in Medicinal Chemistry
|December 30, 2010
PubMed
Summary
This summary is machine-generated.

Optimizing peptide-based copper-64 (⁶⁴Cu) radiotracers improves cancer imaging. Careful design of chelates, linkers, and peptides enhances tumor uptake and image quality for positron emission tomography.

More Related Videos

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Published on: April 29, 2017

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group
07:23

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group

Published on: October 10, 2016

Related Experiment Videos

Last Updated: Jun 5, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Published on: April 29, 2017

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group
07:23

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group

Published on: October 10, 2016

Area of Science:

  • Radiopharmaceutical chemistry
  • Molecular imaging
  • Oncology

Background:

  • Peptide-targeted ⁶⁴Cu radiotracers are crucial for positron emission tomography (PET) cancer imaging.
  • Optimal tumor visualization depends on selective radiotracer uptake.
  • Radiotracer design components (chelate, linker, peptide) critically influence in vivo behavior.

Purpose of the Study:

  • To review the design principles of peptide-targeted ⁶⁴Cu radiotracers for enhanced cancer molecular imaging.
  • To highlight the impact of radiotracer components on biodistribution, stability, and target affinity.
  • To examine case studies of GRPR- and αvβ3 integrin-targeted constructs.

Main Methods:

  • Analysis of radiotracer components: chelate stability, linker properties, and peptide sequence.
  • Evaluation of factors influencing biodistribution: hydrophilicity, metabolic stability, and clearance.
  • Review of specific peptide-targeted ⁶⁴Cu constructs (GRPR, αvβ3 integrin).

Main Results:

  • Cu complex stability is vital to prevent transmetallation and background activity.
  • Linker characteristics affect target receptor affinity.
  • Peptide sequence variations impact metabolic stability, bioavailability, and tumor retention.
  • Hydrophilicity influences radiotracer metabolism and excretion pathways.

Conclusions:

  • Optimized design of chelates, linkers, and peptides is essential for effective ⁶⁴Cu-labeled radiotracers in PET imaging.
  • Targeted approaches, such as GRPR and αvβ3 integrin targeting, show promise for specific cancer detection.
  • Further research into radiotracer design can improve diagnostic accuracy and patient outcomes.